Metabolic dependency profiling guides staggered antibiotic administration to enhance killing of antibiotic-tolerant Acinetobacter baumannii
Abstract
BackgroundAcinetobacter baumannii infections are difficult to eradicate, and bacterial physiological state influences antibiotic killing. However, antibiotic-specific activity across nutrient-associated physiological states and quantitative comparison of these differences remain insufficiently understood.MethodsAcinetobacter baumannii ATCC 19606T was cultured across a nutrient gradient (0–100% LB) to generate nutrient-associated physiological states. Bacterial growth, CFU-normalized intracellular ATP levels, and killing by six antibiotics were quantified. ATP–survival relationships were assessed across standardized concentrations of 0.5×−64×MIC, and a Metabolic Dependency Index (MDI) was developed as a continuous empirical measure of ATP-associated variation in antibiotic killing. Meropenem (MEM) and amikacin (AMK), representing opposite ends of the observed MDI spectrum, were evaluated using simultaneous, MEM-first staggered, and AMK-first staggered administration. The MEM–AMK combination was also examined in five clinical isolates.ResultsNutrient limitation reduced bacterial growth and CFU-normalized intracellular ATP levels and produced antibiotic- and concentration-dependent changes in killing. MDI values differed among antibiotics, with meropenem showing the highest and amikacin the lowest MDI. Simultaneous MEM–AMK treatment enhanced killing compared with the corresponding monotherapies under nutrient-limited conditions. MEM-first staggered administration further reduced bacterial counts relative to simultaneous treatment by 1.21 log10 CFU (95% CI, 0.48–1.94; p = 0.019) and 0.86 log10 CFU (95% CI, 0.47–1.26; p = 0.011) at two prespecified concentration combinations. Reverse-order AMK-first staggered treatment produced killing comparable to or greater than that achieved with MEM-first staggered treatment under several concentration combinations, indicating that the benefit of staggered exposure was not specific to a predefined MEM-first sequence. Similar differences between simultaneous and staggered MEM–AMK administration were observed across five clinical isolates, although the magnitude of these differences varied among isolates. Meropenem and amikacin MICs remained unchanged after antibiotic-free recovery of surviving populations, supporting a tolerance-associated phenotype rather than stable resistance.ConclusionAntibiotic killing in A. baumannii varies across nutrient-associated physiological states in an antibiotic- and concentration-dependent manner. The MDI provides a continuous framework for comparing these differences, while the MEM–AMK experiments show that combination activity can be further influenced by antibiotic administration pattern. These findings provide a basis for integrating bacterial physiological state into the evaluation and optimization of antibiotic combinations under nutrient-limited conditions.
Related
- Polystyrene Microplastics Accelerate Antibiotic Resistance Evolution and Exacerbate Pathogenicity in Acinetobacter Baumannii
- Metabolic acidification–linked outer membrane vesiculation in Acinetobacter baumannii
- Profiling of intestinal T cells reveals antigen-specific dependency on early-life programming for the generation of microbiota-reactive Tregs
- Shared Resistance, Phage-Receptor, and Biofilm Determinants in Antibiotic-Resistant Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii: A Bibliometric and Gene-Network Analysis of Phage Cocktail Research.
- Characterization of central carbon metabolism of Acinetobacter sp. Tol 5 based on 13C-metabolic flux analysis
BibTeX
@article{tuo2026metabolic,
title = {{Metabolic dependency profiling guides staggered antibiotic administration to enhance killing of antibiotic-tolerant Acinetobacter baumannii}},
author = {Ping Tuo and Yuanye Ji and Chunyan Ruan and Sijia Zhang and Fajiu Wang and Jia Shen and Xiaoming Xu and Peng Zhu},
journal = {Frontiers in Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fmicb.2026.1853821},
url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1853821},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Metabolic dependency profiling guides staggered antibiotic administration to enhance killing of antibiotic-tolerant Acinetobacter baumannii
AU - Ping Tuo
AU - Yuanye Ji
AU - Chunyan Ruan
AU - Sijia Zhang
AU - Fajiu Wang
AU - Jia Shen
AU - Xiaoming Xu
AU - Peng Zhu
PY - 2026
DA - 2026/10/29
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.1853821
UR - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1853821
AB - BackgroundAcinetobacter baumannii infections are difficult to eradicate, and bacterial physiological state influences antibiotic killing. However, antibiotic-specific activity across nutrient-associated physiological states and quantitative comparison of these differences remain insufficiently understood.MethodsAcinetobacter baumannii ATCC 19606T was cultured across a nutrient gradient (0–100% LB) to generate nutrient-associated physiological states. Bacterial growth, CFU-normalized intracellular ATP levels, and killing by six antibiotics were quantified. ATP–survival relationships were assessed across standardized concentrations of 0.5×−64×MIC, and a Metabolic Dependency Index (MDI) was developed as a continuous empirical measure of ATP-associated variation in antibiotic killing. Meropenem (MEM) and amikacin (AMK), representing opposite ends of the observed MDI spectrum, were evaluated using simultaneous, MEM-first staggered, and AMK-first staggered administration. The MEM–AMK combination was also examined in five clinical isolates.ResultsNutrient limitation reduced bacterial growth and CFU-normalized intracellular ATP levels and produced antibiotic- and concentration-dependent changes in killing. MDI values differed among antibiotics, with meropenem showing the highest and amikacin the lowest MDI. Simultaneous MEM–AMK treatment enhanced killing compared with the corresponding monotherapies under nutrient-limited conditions. MEM-first staggered administration further reduced bacterial counts relative to simultaneous treatment by 1.21 log10 CFU (95% CI, 0.48–1.94; p = 0.019) and 0.86 log10 CFU (95% CI, 0.47–1.26; p = 0.011) at two prespecified concentration combinations. Reverse-order AMK-first staggered treatment produced killing comparable to or greater than that achieved with MEM-first staggered treatment under several concentration combinations, indicating that the benefit of staggered exposure was not specific to a predefined MEM-first sequence. Similar differences between simultaneous and staggered MEM–AMK administration were observed across five clinical isolates, although the magnitude of these differences varied among isolates. Meropenem and amikacin MICs remained unchanged after antibiotic-free recovery of surviving populations, supporting a tolerance-associated phenotype rather than stable resistance.ConclusionAntibiotic killing in A. baumannii varies across nutrient-associated physiological states in an antibiotic- and concentration-dependent manner. The MDI provides a continuous framework for comparing these differences, while the MEM–AMK experiments show that combination activity can be further influenced by antibiotic administration pattern. These findings provide a basis for integrating bacterial physiological state into the evaluation and optimization of antibiotic combinations under nutrient-limited conditions.
SN - 1664-302X
ER -